UMIP Fellows recruited and ready to go for the 4th Year!

Written by UMIP on . Posted in News

The Fellows Team

The Fellows Team

Our Fellows programme is modelled on the similar, highly successful Columbia Fellows Programme run at Columbia University in New York and offers a unique opportunity for full-time postgraduate students registered at the University to gain in-depth experience in technology commercialisation activities.

For 2016/17, we have just recruited 10 UMIP Fellows from across the University who will work with our Commercialisation Executives on a part-time paid basis.

A Training Day was held on 26th September at our Innovation Centre to introduce our new Fellows to the skills needed to undertake a variety of assignments to support UMIP’s activities. These include completing initial assessments of the commercial viability of new inventions, including how to identify potential applications and competitors, development of marketing materials for technologies, creating lists of companies for potential collaboration or licensing and analysis of patent literature. Fellows will also have access to and support from the team at the Manchester Enterprise Centre during the one-year term of their appointment.

Tony Walker, Director of Innovation Optimiser at UMIP, commented: “It is great to get so much interest in the Fellows Programme and enthusiasm from students here. The benefits to both students and UMIP have clearly been demonstrated over the past three years. For UMIP, the Fellows provided valuable start-points for our detailed analysis of the commercial potential of new invention disclosures collected in the year, and for our promotion of technology externally. I would like to thank the Manchester Enterprise Centre for their close involvement and support of the UMIP Fellows Programme.”

Dr Martin Henery, Enterprise Academic / Lecturer & Social Enterprise Champion at Manchester Enterprise Centre, commented:” It is very exciting to see the UMIP Fellows Programme entering a fourth year and enabling students interested in enterprise to get hands-on experience of real technology commercialisation cases.”

For additional information about our Fellow Programme, please contact: Margaret Lewis on 0161 306 3067 or

University of Manchester leaps up global innovation list

Written by UMIP on . Posted in News

The University of Manchester has climbed to 87th place in the world in this year’s Reuters Top 100 Most Innovative Universities as a result of the high commercial impact of its patents, and is 17th in Europe and 4th in the UK.

This is the second year of the Reuter’s list, which is once again topped by Stanford University in the United States. Manchester is one of only five UK universities to make the top 100 and has moved up from 95th in 2015.

The profile of Manchester on the Reuters site refers to the University’s impressive record of establishing more than 100 spin-out companies including Clin-E-Cal, which has created an interactive app to aid children with asthma breathe more easily, and Spectromics, which is developing an innovative point-of-prescription test for bacterial infections which guides the treatment of antibiotics.

The ranking is also based on the number of citations of papers in patents, to introduce a quality rather than a volume measure, with one strategic patenting area, graphene, which earned the University’s discoverers Andre Geim and Kostya Novoselov the Nobel Prize for Physics in 2010, referred to as a major breakthrough.

The University’s National Graphene Institute is now accelerating the process of using the wonder-material in real-world technologies such as energy efficient batteries and water desalination. The University is now building a Graphene Engineering Innovation Centre.

Clive Rowland, CEO of UMI3 Ltd, The University of Manchester’s Innovation Company, commented: “the University continues to promote its long standing commitment to improving society through innovation, whether such positive impacts are achieved by our social enterprises or for commercial gain through our spin-out company and technology licensing work. We recognise that to be an innovative organisation we need to look for quality as well as volume with our patenting. It’s pleasing to see that our results focussed approach and continuous improvement in our way of working, that we introduced some time ago, is having an effect as shown by our upward movement in this index. The difference between us and those towards the top of the table, in respect of the impact measure, is narrowing too.”

Manchester’s placing on the Reuters rankings is one of a number of strong showings in international university league tables of late. This includes a highest ever place of 29th in the respected QS World University Rankings and another all-time high of 35th in the ‘Academic Ranking of World Universities’ table.

The full Reuters ranking is available here:




Social Enterprise Ignition Funding Opportunity – 2016

Written by UMIP on . Posted in News

Social Entrepreneurs are born out of the desire to improve the world and make it a better place. They may see problems in their community and undertake activity to solve it. A social enterprise simply delivers this solution and vision.

Since 2012 we have granted 46 awards allocating over £155000 to Social Entrepreneurs across the University.

We are now seeking to ignite the next generation of individuals interested in pursuing a social business:

  • Are you currently working or studying at The University of Manchester or a recent graduate?
  • Is your idea likely to benefit the public or community, or be an entrepreneurial solution to a societal, healthcare or environmental problem?
  • Do you have the passion to drive your idea forward and set up a project or social business?*Please provide your full contact details, job title or student status and a brief outline of your idea

To find out more about this funding call, please register* your interest by email to by the 23rd September 2016

*Please provide your full contact details, job title or student status and a brief outline of your idea

Please see our PDF flyer here

Environnement S.A Group acquires TDL  Sensors Ltd

Written by UMIP on . Posted in Uncategorized

Environnement S.A. Group, leading European supplier of environmental monitoring equipment, and the company TDL Sensors Ltd, high technology innovative company supplying laser based monitors for industrial applications, are proud to announce the acquisition of TDL Sensors Ltd by Environnement S.A. Group. It allows the enlarged group to offer worldwide, the most advanced and wide range of solutions to match present and future challenges in respect of process or regulatory environmental monitoring requirements for industries.

This alliance will immediately contribute to the market release of a new range of innovative laser based emission monitors such as ultra-low detection of HCI emissions, and accelerate both Research and Development in joint projects.

Environnement S.A. Group commitment to the development of advanced instrumentation for global market is reinforced with the acquisition of TDL Ltd. TDL Ltd will retain its current management team and employees and plans to recruit additional product development professionals.

The management of TDL Ltd and the broader Environnement S.A. Group (including its existing UK subsidiary PCME Ltd) will focus efforts to the anticipated strong growth provided by synergies within the Group. It will benefit their respective customers, partners and employees in terms of expertise, quality and services.

François Gourdon, President and founder of Environnement S.A. declares “We are very enthusiastic about the opportunities that we’ll be able to provide to our worldwide customers. The expertise of TDL Sensors Ltd through Tunable lasers (including cascade lasers) for the monitoring of high-resolution gas concentration in industrial processes, combined with the expertise of Environnement S.A. Group in the monitoring of gas and particulate, will definitively help to anticipate the worldwide requirements for much lower emissions.”

Roger Benson, Chairman of TDL Sensors Ltd adds: “This strong partnership announced today will boost TDL Sensors Ltd growth plan and strategy, allowing our technology to reach new customers and new markets, while strengthening our capacity to develop new applications (on road vehicle emissions, carbon policies and carbon trade monitoring devices…)”.


Environnement S.A., the European leading manufacturer of on-line environmental monitors whose headquarters are based in Poissy (France), is a Public company since January 2006 listed on NYSE-Alternext.

Founded in 1978, the Environnement S.A. Group provides solutions to public and industrial decision makers responsible for environmental policy and compliance, helping them monitor and evaluate their ecological footprint. The company has developed advanced expertise in the following continuous monitoring fields: air quality, industrial emission, engine gas, water quality and radionuclide.

About TDL Sensors Ltd (

TDL Sensors Ltd was founded in 1999 and spun out of the Department of Chemical Engineering, University of Manchester, to develop a tunable diode laser based gas analyzers. In the following years, TDL Sensors Ltd have developed measurement solutions for the glass coating industry, ultra-harsh processes, enclosed atmospheres for the protection of personnel, trace gas monitoring for the oil and gas industries and for the optimization of combustion in Steel Industries.


The staged acquisition of Phagenesis by Nestlé Health Science will benefit patients with dysphagia

Written by UMIP on . Posted in News

Manchester, England, 1 September 2016 – Nestlé Health Science (NHSc) and Phagenesis announced today that NHSc is entering into a staged, milestone-based acquisition of Phagenesis, a medical device company that has developed a new treatment for dysphagia.

Under the terms of the agreement, NHSc will make an upfront payment, followed by milestone-based funding, while Phagenesis completes the clinical evaluation of Phagenyx®*. The staged acquisition will be based upon successful completion of European and US development programs anticipated by 2019. Financial terms have not been disclosed.

Reinhard Krickl, CEO of Phagenesis, said: “Nestlé Health Science is the leading global player in dysphagia with capabilities and reach to enable Phagenesis to accelerate the development and deployment of Phagenyx® to patients around the world.”

Dysphagia, the inability to swallow safely, is a condition with high prevalence as well as high clinical and health economic burden. Dysphagia occurs in around 29% to 55% of stroke patients1, with 15 million people worldwide suffering a stroke2 every year. It is also a common consequence of numerous other diseases, and is often under-diagnosed in various patient populations, e.g. in the ICU. Dysphagia is a debilitating condition that frequently leads to life-threatening complications, including aspiration pneumonia, malnutrition and dehydration. Furthermore, patients with dysphagia experience a dramatic reduction in Quality-of-Life3.

Oern Stuge, Chairman of Phagenesis, said: “Nestlé Health Science’ investment positions the company well to address this immense unmet medical need.”

Currently, the management of neurogenic dysphagia is complex. Available options can improve the status and the symptoms, but few are treating the cause. Phagenesis has developed Phagenyx®, a novel medical device designed to restore the neurological control of swallowing. Phagenyx® is based on ground breaking research that establishes a mechanism of action of delivering Pharyngeal Electrical Stimulation (PES) to treat the neurological cause of dysphagia.

Gunnar Weikert, Director of Phagenesis and Founder of Inventages Venture Capital, commented: “As a long-term investor in Phagenesis we are pleased about this significant investment by Nestle Health Science.”

Greg Behar, CEO of Nestlé Health Science, stated: “Dysphagia is a strategic focus for Nestlé Health Science. This innovation can bring a new dimension to swallowing rehabilitation that can be transformational from a patient and healthcare professional perspective.” 


* Phagenyx® is CE marked in Europe. In the United States, Phagenyx® is currently not available for sales.


1       Martino, R., Foley N., Bhogalet S. et al. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke 2005; 36, 2756–2763.


3       Marik P et al. Aspiration Pneumonia and Dysphagia in the Elderly. Chest 2003.124;328-336.



Privacy Policy / Terms and Conditions / © Copyright 2015 The University of Manchester Intellectual Property / Created by HTP Digital Marketing Agency

The University of Manchester Intellectual Property ("UMIP") acts solely as agent for the University in relation to any matter relating to intellectual property ("IP") and know how created at the University. This is whether such IP is created by employees, students or others. UMIP does not represent anyone else in such matters. If anyone else requires advice in relation to such IP then they must take their own independent legal advice.